Allan Jordan
Vice President, Oncology Drug Discovery Sygnature Discovery
Seminars
Monday 23rd February 2026
Panel Discussion: What’s the New Path to the Next Generation of ADCs?
10:30 am
- Understanding how to migrate from non-selective ADC payloads
- Debating the right properties for a next generation payload and linker: Can (or should?) any small molecule therapeutic be developed into an ADC?
- Debating the right strategy for dual-payload ADCs
- Understanding ADC toxicity and developability for next-generation conjugates
Panel Session Hosted By:
